A novel DAG-dependent mechanism links PKCɑ and Cyclin B1 regulating cell cycle progression

Oncotarget. 2014 Nov 30;5(22):11526-40. doi: 10.18632/oncotarget.2578.

Abstract

Through the years, different studies showed the involvement of Protein Kinase C (PKC) in cell cycle control, in particular during G1/S transition. Little is known about their role at G2/M checkpoint. In this study, using K562 human erythroleukemia cell line, we found a novel and specific mechanism through which the conventional isoform PKCα positively affects Cyclin B1 modulating G2/M progression of cell cycle. Since the kinase activity of this PKC isoform was not necessary in this process, we demonstrated that PKCα, physically interacting with Cyclin B1, avoided its degradation and stimulated its nuclear import at mitosis. Moreover, the process resulted to be strictly connected with the increase in nuclear diacylglycerol levels (DAG) at G2/M checkpoint, due to the activity of nuclear Phospholipase C β1 (PLCβ1), the only PLC isoform mainly localized in the nucleus of K562 cells. Taken together, our findings indicated a novel DAG dependent mechanism able to regulate the G2/M progression of the cell cycle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus
  • Cell Cycle
  • Cell Line, Tumor
  • Cell Nucleus / metabolism
  • Cell Separation
  • Cyclin B1 / metabolism*
  • Diglycerides / chemistry*
  • Flow Cytometry
  • Humans
  • Isoenzymes / metabolism
  • K562 Cells
  • Microscopy, Fluorescence
  • Mitosis
  • Phospholipase C beta / metabolism
  • Protein Kinase C-alpha / metabolism*

Substances

  • CCNB1 protein, human
  • Cyclin B1
  • Diglycerides
  • Isoenzymes
  • PRKCA protein, human
  • Protein Kinase C-alpha
  • PLCB1 protein, human
  • Phospholipase C beta